Found: 35
Select item for more details and to access through your institution.
BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 3913, doi. 10.3390/ijms22083913
- By:
- Publication type:
- Article
An SNF2 factor involved in mammalian development and cellular proliferation.
- Published in:
- Developmental Dynamics, 2001, v. 221, n. 1, p. 92, doi. 10.1002/dvdy.1128
- By:
- Publication type:
- Article
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10043-0
- By:
- Publication type:
- Article
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1311, doi. 10.3390/cancers14051311
- By:
- Publication type:
- Article
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
- Published in:
- Laryngoscope, 2024, v. 134, n. 7, p. 3253, doi. 10.1002/lary.31387
- By:
- Publication type:
- Article
The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01521-0
- By:
- Publication type:
- Article
Conditional reprogramming culture conditions facilitate growth of lower-grade glioma models.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 5, p. 770, doi. 10.1093/neuonc/noaa263
- By:
- Publication type:
- Article
The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 4, p. 572, doi. 10.1093/neuonc/noaa235
- By:
- Publication type:
- Article
Response to letter to the editor: "All models are wrong; some models are useful".
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1406, doi. 10.1093/neuonc/noaa137
- By:
- Publication type:
- Article
Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 4, p. 563, doi. 10.1093/neuonc/noz230
- By:
- Publication type:
- Article
LGG-15. COMBINED SUPPRESSION OF THE MTOR AND MAPK PATHWAYS INHIBITS CELL PROLIFERATION AND DECREASES VASCULARITY IN PEDIATRIC LOW GRADE GLIOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii102, doi. 10.1093/neuonc/noz036.158
- By:
- Publication type:
- Article
LGG-09. PD-L1 EXPRESSION IN PEDIATRIC LOW GRADE GLIOMAS, AN OPPORTUNITY FOR INTERVENTION INDEPENDENT OF BRAF MUTATIONAL STATUS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii100, doi. 10.1093/neuonc/noz036.152
- By:
- Publication type:
- Article
HGG-25. TARGETING THE EPIGENETIC MODIFIER HMGA2 IN DIPG AND HIGH GRADE GLIOMAS INHIBITS PROLIFERATION, INVASION AND TUMORIGENICITY.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii92, doi. 10.1093/neuonc/noz036.119
- By:
- Publication type:
- Article
ATRT-12. BINIMETINIB SUPPRESSES THE GROWTH OF ATYPICAL TERATOID/RHABDOID TUMOR CELLS AND INDUCES APOPOTOSIS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii65, doi. 10.1093/neuonc/noz036.011
- By:
- Publication type:
- Article
ATRT-04. UNBIASED METABOLIC PROFILING OF ATYPICAL TERATOID/RHABDOID TUMORS PREDICTS SENSITIVITY TO GLUTAMINE METABOLIC INHIBITORS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii63, doi. 10.1093/neuonc/noz036.003
- By:
- Publication type:
- Article
Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 2, p. 252, doi. 10.1093/neuonc/noy150
- By:
- Publication type:
- Article
PDCT-02. COMBINED INHIBITION OF MTORC1/C2 AND MEK PATHWAY IS SYNERGISTIC IN PRECLINICAL TESTING OF PEDIATRIC LOW-GRADE GLIOMA INCLUDING A NOVEL PATIENT-DERIVED NF1 PILOCYTIC ASTROCYTOMA CELL LINE.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi200, doi. 10.1093/neuonc/noy148.832
- By:
- Publication type:
- Article
The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 10, p. 1361, doi. 10.1093/neuonc/nox067
- By:
- Publication type:
- Article
The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1068, doi. 10.1093/neuonc/now299
- By:
- Publication type:
- Article
HIGHLY SELECTIVE INTRA-ARTERIAL CHEMOTHERAPY FOR THE TREATMENT OF PROGRESSIVE DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG).
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii29, doi. 10.1093/neuonc/nou208.24
- By:
- Publication type:
- Article
MODELLING HIGH MYC MEDULLOBLASTOMA AND OTHER BRAIN TUMORS USING HUMAN NEURAL STEM CELLS.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii4, doi. 10.1093/neuonc/nou206.12
- By:
- Publication type:
- Article
Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 12, p. 1604, doi. 10.1093/neuonc/not132
- By:
- Publication type:
- Article
Management of Pediatric and Adult Patients with Medulloblastoma.
- Published in:
- Current Treatment Options in Oncology, 2014, v. 15, n. 4, p. 581, doi. 10.1007/s11864-014-0306-4
- By:
- Publication type:
- Article
ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres.
- Published in:
- Brain Pathology, 2015, v. 25, n. 6, p. 724, doi. 10.1111/bpa.12240
- By:
- Publication type:
- Article
Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 5, p. 1246, doi. 10.1002/ijc.29873
- By:
- Publication type:
- Article
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 4, p. 1, doi. 10.1038/s41419-022-04868-9
- By:
- Publication type:
- Article
ASXL1 inactivation and reduced H3K27me3 across central nervous system tumors.
- Published in:
- Acta Neuropathologica, 2024, v. 148, n. 1, p. 1, doi. 10.1007/s00401-024-02785-z
- By:
- Publication type:
- Article
Correction to: Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.
- Published in:
- Acta Neuropathologica, 2014, v. 127, n. 6, p. 881, doi. 10.1007/s00401-013-1218-2
- By:
- Publication type:
- Article
A glioblastoma neurosphere line with alternative lengthening of telomeres.
- Published in:
- 2013
- By:
- Publication type:
- Letter
High-risk medulloblastoma: Does c-myc amplification overrule histopathology?
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 3, p. 344, doi. 10.1002/pbc.22398
- By:
- Publication type:
- Article
Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 51, n. 1, p. 10, doi. 10.1002/pbc.21475
- By:
- Publication type:
- Article
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 8, p. 1357, doi. 10.1093/neuonc/noae074
- By:
- Publication type:
- Article
ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0204159
- By:
- Publication type:
- Article
Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high‐MYC medulloblastoma.
- Published in:
- Neuropathology, 2019, v. 39, n. 2, p. 71, doi. 10.1111/neup.12534
- By:
- Publication type:
- Article